Brief: Moberg Pharma Q3 EBITDA up at SEK 36.0 mln

Moberg Pharma AB (publ)

13/11/2017 07:00

Nov 13 (Reuters) - MOBERG PHARMA  MBPH.ST : 
    * Q3 EBITDA SEK 36.0 MILLION VERSUS 29.0 MILLION YEAR AGO 
    * Q3 REVENUE SEK 108.3 MILLION VERSUS  SEK 104.1 MILLION 
YEAR 
AGO 
 
Source text for Eikon:  ID:nWkr3VnhYh  
Further company coverage:  MBPH.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))